Humanetics Corporation: Funding, Investors & Team (Oct 2026)
Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. The Company was founded in 1988 and is engaged in developing and commercializing products to enhance human health and wellbeing. Humanetics entered the field of radiation modulators in 2003, through a cooperative research program with the Armed Forces Radiobiology Research Institute (AFRRI). Humanetics began working with AFRRI to test an array of drug candidates using their highly developed capabilities. From this program, BIO 300 emerged as a lead candidate and the underlying technology was in-licensed from AFRRI to Humanetics. In the ensuing years, the Company has progressed this program into multiple clinical uses with a primary focus on improving treatment of solid tumor cancers.
Humanetics Corporation has raised $5.0M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Dec 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Humanetics Corporation Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Humanetics Corporation Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Humanetics Corporation announced an undisclosed round in Oct 2023; the amount was not disclosed.
1.2 years later, an undisclosed round of $5.0M was announced in Dec 2024.
Humanetics Corporation Founders and Leadership Team
Contact details for the Humanetics Corporation team: 1 of 1 has an email address on file.
Start 14-day free trial →Humanetics Corporation Funding Compared to Other Biotechnology Startups
Humanetics Corporation's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Humanetics Corporation in Biotechnology and Minneapolis
Companies Similar to Humanetics Corporation
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Humanetics Corporation Funding FAQs
What does Humanetics Corporation do?
Humanetics is a privately held, clinical stage pharmaceutical company located in the Minneapolis metropolitan area. The Company was founded in 1988 and is engaged in developing and commercializing products to enhance human health and wellbeing. Humanetics entered the field of radiation modulators in 2003, through a cooperative research program with the Armed Forces Radiobiology Research Institute (AFRRI). Humanetics began working with AFRRI to test an array of drug candidates using their highly developed capabilities. From this program, BIO 300 emerged as a lead candidate and the underlying technology was in-licensed from AFRRI to Humanetics. In the ensuing years, the Company has progressed this program into multiple clinical uses with a primary focus on improving treatment of solid tumor cancers.
How much funding has Humanetics Corporation raised?
Humanetics Corporation has raised $5.0M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Dec 2024.
When did Humanetics Corporation last raise funding?
Humanetics Corporation's most recent funding round on record is an undisclosed round of $5.0M, announced in Dec 2024.
Who founded Humanetics Corporation?
FundedIQ lists Ronald Zenk (Founder) at Humanetics Corporation.
Where is Humanetics Corporation headquartered?
Humanetics Corporation is based in Minneapolis, Minnesota, United States.
How many employees does Humanetics Corporation have?
Humanetics Corporation is in the 11-50 employee band.
How does Humanetics Corporation's funding compare to other Biotechnology startups?
Humanetics Corporation's latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Humanetics Corporation Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Humanetics Corporation is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.